Tyme, Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of SM-88 in Advanced Cancers (NCT02562612) | Tyme, Inc | 2022-10-01 |
| A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer (NCT03512756) | Tyme, Inc | 2018-03-27 |
Track Tyme, Inc automatically
Every clearance here is in the API, with alerts when new ones post.